HPV vaccine and cervical screening for women with HIV
Treatments studied
Part of Immune system & allergy, Infections clinical trials.
This study looks at whether getting the HPV vaccine along with regular cervical cancer screening (using an HPV test) can help prevent cervical cancer in women living with HIV. It is designed to be done as part of your usual HIV clinic visits, making it easier for you to take part.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman living with HIV.
- You are between 25 and 35 years old.
- You regularly attend an HIV clinic for your care.
- You are not currently pregnant and it has been at least 3 months since you gave birth.
- You still have your cervix (you have not had a hysterectomy).
- You can commit to staying in the same city for the next 2 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to help women living with HIV get screened for cervical cancer: one uses only clinic visits, the other adds community outreach and self-testing for HPV at home. It aims to increase screening rates and catch early signs of cervical cancer.
This trial compares two ways to help women with HIV get screened for cervical cancer: a clinic-based approach versus a combined clinic and community outreach program. You may be able to provide samples yourself at a clinic or at home to test for HPV, the virus that can cause cervical cancer.
This study looks at how HPV (the virus that can cause cervical cancer) and the natural balance of bacteria in the vagina affect women who have HIV. It may help doctors understand how to better prevent cervical cancer in women with weakened immune systems.
This study looks at how well the HPV vaccine works in women living with HIV and whether it helps make cervical cancer screening more accurate. If you are a woman with HIV between 21 and 40 years old and already part of certain other HIV studies, you may be able to join.
This trial tests an HPV vaccine in people living with HIV to see if it is safe and helps their immune system fight HPV. HPV can cause certain cancers, and this study hopes to protect people with HIV who are more at risk.
This study looks at ways to improve cervical cancer screening and follow-up for women with HIV. If you are a woman with HIV aged 25 or older, this research may help understand how to make screening easier and more available.
Hear when a new HPV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.